Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.

DOD

Discussions

Biomedical Jobmarket

News

DOD Alert

Edit DOD

ACCOUNT

Forgotten Password?


Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > GLP-1 > Effectivity of GLP-1 in Therapy > Degradation by Dipeptidyl Peptidase IV > Dipeptidyl-Peptidase IV Inhibitors > Journal Article

(Journal Article): Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.

Deacon CF, Holst JJ (Department of Medical Physiology, The Panum Institute, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark., deacon@mfi.ku.dk )

IN: Biochem Biophys Res Commun 2002; 294(1):1-4
Impact Factor(s) of Biochem Biophys Res Commun: 2.904 (2004), 2.836 (2003), 2.935 (2002), 2.946 (2001)

Fulltext: HTML PDF

ABSTRACT: n.a.

TYPE OF PUBLICATION: Comment

Articles citing this article:

Gallwitz B. New Therapeutic Strategies for the Treatment of Type 2 Diabetes Mellitus Based on Incretins. Rev Diabetic Stud 2005. 2: 61-69.
» Diabetes OD » Disease Management » T2DM » Metabolic Control » Anti-Hyperglycemic and Anti-Ap... » Incretin Hormones » GLP-1 » Effectivity of GLP-1 in Therap... » Journal Article

Respond on this Journal Article!
Hint: Your Response should directly apply to Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.. Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate subject area. The actual subject area is Dipeptidyl-Peptidase IV Inhibitors.

About DOD | Advertising Information | Support The Project | DOD alert | Become Editor